Public Sector Pension Investment Board (PSP Investments)’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.27M Sell
199,351
-5,807
-3% -$279K 0.02% 692
2026
Q1
$10.6M Buy
205,158
+6,752
+3% +$344K 0.03% 527
2025
Q4
$9.86M Sell
198,406
-20,278
-9% -$986K 0.03% 494
2025
Q3
$10.5M Sell
218,684
-1,620
-0.7% -$65.2K 0.04% 428
2025
Q2
$6.94M Buy
220,304
+573
+0.3% +$18.4K 0.03% 529
2025
Q1
$7.2M Buy
219,731
+82,167
+60% +$2.91M 0.03% 515
2024
Q4
$4.97M Buy
137,564
+20,615
+18% +$726K 0.02% 650
2024
Q3
$3.65M Sell
116,949
-4,000
-3% -$125K 0.02% 628
2024
Q2
$3.24M Buy
120,949
+8,967
+8% +$260K 0.02% 623
2024
Q1
$3.82M Sell
111,982
-1,390
-1% -$41.4K 0.03% 492
2023
Q4
$3.28M Buy
113,372
+45,895
+68% +$1.22M 0.02% 552
2023
Q3
$1.86M Sell
67,477
-29,219
-30% -$889K 0.01% 804
2023
Q2
$2.91M Buy
96,696
+1,621
+2% +$56.7K 0.02% 710
2023
Q1
$3.44M Sell
95,075
-2,982
-3% -$115K 0.02% 609
2022
Q4
$3.5M Hold
98,057
0.03% 602
2022
Q3
$3.32M Sell
98,057
-818
-0.8% -$26.6K 0.03% 549
2022
Q2
$2.86M Sell
98,875
-381
-0.4% -$10.9K 0.02% 593
2022
Q1
$3.21M Sell
99,256
-9,090
-8% -$279K 0.02% 727
2021
Q4
$3.16M Hold
108,346
0.02% 835
2021
Q3
$2.89M Hold
108,346
0.02% 890
2021
Q2
$3.34M Sell
108,346
-23,403
-18% -$717K 0.02% 808
2021
Q1
$3.45M Sell
131,749
-17,938
-12% -$502K 0.02% 694
2020
Q4
$3.77M Buy
149,687
+14,296
+11% +$308K 0.03% 581
2020
Q3
$2.82M Buy
135,391
+17,895
+15% +$406K 0.02% 685
2020
Q2
$2.79M Hold
117,496
0.03% 613
2020
Q1
$2.11M Hold
117,496
0.02% 605
2019
Q4
$2.79M Sell
117,496
-16,300
-12% -$396K 0.02% 952
2019
Q3
$3.68M Buy
133,796
+18,332
+16% +$543K 0.02% 714
2019
Q2
$3.82M Buy
115,464
+20,800
+22% +$713K 0.03% 558
2019
Q1
$3.32M Buy
94,664
+9,597
+11% +$357K 0.03% 454
2018
Q4
$2.83M Buy
85,067
+48,803
+135% +$2.1M 0.02% 478
2018
Q3
$1.83M Buy
36,264
+2,948
+9% +$146K 0.01% 677
2018
Q2
$1.99M Hold
33,316
0.01% 489
2018
Q1
$1.53M Sell
33,316
-15,200
-31% -$634K 0.01% 537
2017
Q4
$1.93M Buy
48,516
+16,800
+53% +$664K 0.01% 539
2017
Q3
$1.27M Buy
31,716
+5,916
+23% +$256K 0.01% 656
2017
Q2
$1.11M Sell
25,800
-9,200
-26% -$327K 0.01% 688
2017
Q1
$1.1M Hold
35,000
0.01% 830
2016
Q4
$884K Hold
35,000
0.01% 903
2016
Q3
$866K Buy
35,000
+11,600
+50% +$263K 0.01% 871
2016
Q2
$477K Hold
23,400
0.01% 1050
2016
Q1
$357K Hold
23,400
﹤0.01% 1091
2015
Q4
$314K Sell
23,400
-14,900
-39% -$230K ﹤0.01% 1124
2015
Q3
$537K Sell
38,300
-5,400
-12% -$100K ﹤0.01% 1095
2015
Q2
$742K Buy
+43,700
New +$622K 0.01% 1132

Other funds holding SUPN

Public Sector Pension Investment Board (PSP Investments)'s SUPN Position: Q2 2026 in Review

Public Sector Pension Investment Board (PSP Investments) reduced its Supernus Pharmaceuticals (SUPN) stake by 2.8% in Q2 2026, selling an estimated $279K and leaving 199,351 shares worth $9.27M. The position accounts for 0.02% of the portfolio, ranked #692.

Public Sector Pension Investment Board (PSP Investments) first reported a position in SUPN in Q2 2015 and has held it in 45 quarters since. The position peaked at $10.6M in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 199,351 shares of Supernus Pharmaceuticals worth $9.27M as of Q2 2026.
  • Public Sector Pension Investment Board (PSP Investments) sold 5,807 Supernus Pharmaceuticals shares in Q2 2026, an estimated $279K.
  • Supernus Pharmaceuticals made up 0.02% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q2 2026, its #692 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 45 quarters since.
  • Public Sector Pension Investment Board (PSP Investments)'s Supernus Pharmaceuticals position peaked at $10.6M in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2026, filed 13 Aug 2026.